A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)

Clinical trial NCT00500006 · TERMINATED

Trial details

NCT number: NCT00500006
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Start date: 2007-10-01
Primary completion: 2007-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.